Ethyl 4-[3-(2-tert-butoxy-2-oxoethyl)-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl]benzoate → HCID 18449375, 화합물
반응식
O=C1N(CC(OC(C)(C)C)=O)C2C=CC=CC=2N1.C([O:23][C:24](=[O:47])[CH2:25][N:26]1[C:30]2[CH:31]=[CH:32][CH:33]=[CH:34][C:29]=2[N:28]([C:35]2[CH:45]=[CH:44][C:38]([C:39]([O:41][CH2:42][CH3:43])=[O:40])=[CH:37][CH:36]=2)[C:27]1=[O:46])(C)(C)C>>[CH2:42]([O:41][C:39]([C:38]1[CH:37]=[CH:36][C:35]([N:28]2[C:29]3[CH:34]=[CH:33][CH:32]=[CH:31][C:30]=3[N:26]([CH2:25][C:24]([OH:47])=[O:23])[C:27]2=[O:46])=[CH:45][CH:44]=1)=[O:40])[CH3:43]참가 물질
3
실험 절차
Essentially following the procedures described for Intermediate 4, but using ethyl 4-[3-(2-tert-butoxy-2-oxoethyl)-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl]benzoate in place of tert-butyl (2-oxo-3-pyridin-2-yl-2,3-dihydro-1H-benzimidazol-1-yl)acetate, the title compound was prepared. MS: m/z=341 (M+1).
출처 및 근거
- ORD 기록
- ord-74b72828abb0414fbc0609bb27b00c49
- 출처 데이터셋
- uspto-grants-2007_04